UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$321M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$214M |
| 3 |
Zimmer Biomet
ZBH
|
+$207M |
| 4 |
Ecolab
ECL
|
+$192M |
| 5 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$189M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$251M |
| 2 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$225M |
| 3 |
AGN
Allergan Inc
AGN
|
+$221M |
| 4 |
Apple
AAPL
|
+$201M |
| 5 |
American Express
AXP
|
+$180M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.57% |
| 2 | Technology | 14.63% |
| 3 | Financials | 14.16% |
| 4 | Consumer Discretionary | 9.69% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Rexford Industrial Realty
REXR
$8.19B
| $621K | ﹤0.01% |
+39,256
| New | +$629K |
|
|
SYNT
1802
DELISTED
Syntel Inc
SYNT
| $621K | ﹤0.01% |
12,000
+600
| +5% | +$28.5K |
|
1803
Genesco
GCO
$422M
| $620K | ﹤0.01% |
8,699
+400
| +5% | +$29K |
|
1804
Rambus
RMBS
$11B
| $620K | ﹤0.01% |
49,296
+2,200
| +5% | +$25.9K |
|
|
BCPC
1805
Balchem Corp
BCPC
$5.72B
| $620K | ﹤0.01% |
11,199
+400
| +4% | +$22.9K |
|
|
PIR
1806
DELISTED
Pier 1 Imports, Inc.
PIR
| $620K | ﹤0.01% |
2,217
+85
| +4% | +$24.6K |
|
1807
ASML
ASML
$669B
| $619K | ﹤0.01% |
6,124
-59
| -1% | -$6.2K |
|
|
AXON
1808
Axon Enterprise
AXON
$46.4B
| $617K | ﹤0.01% |
25,598
+1,200
| +5% | +$30.5K |
|
1809
Insperity
NSP
$2.01B
| $617K | ﹤0.01% |
23,598
+1,200
| +5% | +$27.9K |
|
|
OWW
1810
DELISTED
ORBITZ WORLDWIDE, INC
OWW
| $617K | ﹤0.01% |
52,900
+14,000
| +36% | +$148K |
|
1811
Universal Corp
UVV
$1.27B
| $616K | ﹤0.01% |
13,054
+5,755
| +79% | +$255K |
|
|
ARI
1812
Apollo Commercial Real Estate
ARI
$885M
| $615K | ﹤0.01% |
35,834
+13,036
| +57% | +$219K |
|
1813
Forward Air
FWRD
$654M
| $614K | ﹤0.01% |
11,299
+500
| +5% | +$25.6K |
|
1814
TFS Financial
TFSL
$4.93B
| $612K | ﹤0.01% |
41,695
+2,400
| +6% | +$34.4K |
|
1815
The Ensign Group
ENSG
$10.7B
| $609K | ﹤0.01% |
27,794
+3,421
| +14% | +$69.6K |
|
1816
Strategy Inc
MSTR
$38.4B
| $609K | ﹤0.01% |
36,000
+1,000
| +3% | +$16.9K |
|
1817
Comscore
SCOR
$109M
| $609K | ﹤0.01% |
595
+30
| +5% | +$28.2K |
|
1818
TriMas Corp
TRS
$1.44B
| $607K | ﹤0.01% |
24,722
+1,255
| +5% | +$29.6K |
|
|
SWIR
1819
DELISTED
Sierra Wireless
SWIR
| $606K | ﹤0.01% |
18,298
+600
| +3% | +$22.5K |
|
1820
ICU Medical
ICUI
$4.61B
| $605K | ﹤0.01% |
6,500
+300
| +5% | +$26.2K |
|
1821
LiveRamp
RAMP
$2.3B
| $605K | ﹤0.01% |
32,697
+1,400
| +4% | +$26.9K |
|
|
SAFM
1822
DELISTED
Sanderson Farms Inc
SAFM
| $605K | ﹤0.01% |
7,599
+400
| +6% | +$32.5K |
|
1823
International Bancshares
IBOC
$4.57B
| $604K | ﹤0.01% |
23,198
+1,200
| +5% | +$29.5K |
|
|
PCH
1824
DELISTED
PotlatchDeltic
PCH
| $601K | ﹤0.01% |
14,999
+600
| +4% | +$24.3K |
|
|
MCRL
1825
DELISTED
MICREL INC
MCRL
| $600K | ﹤0.01% |
39,798
+900
| +2% | +$13.1K |
|
Similar funds
UBS AM's Q1 2015 Portfolio in Review
As of Q1 2015, UBS AM held 2,695 positions worth $104B, down 1.3% from $105B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM withdrew a net $4.3B in Q1 2015, closing 72 positions and reducing 841 holdings. Its most notable exit was Allergan Inc, an estimated $221M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, UBS AM opened a new position in Qorvo worth $36M.
- UBS AM's largest Q1 2015 buy was Qorvo: 451,878 shares worth $36M.
- UBS AM added most to Allergan plc in Q1 2015, an estimated $321M increase.
- UBS AM's biggest Q1 2015 reduction was Walgreens Boots Alliance, cutting an estimated $251M.
- UBS AM fully exited Allergan Inc in Q1 2015, selling an estimated $221M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q1 2015.
- UBS AM opened 84 new positions and closed 72 in Q1 2015.
- UBS AM's portfolio value fell 1.3% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q1 2015, filed 4 May 2015.